Alto Neuroscience Statistics
NYSE: ANROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
23.52-0.17 (-0.72%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Alto Neuroscience by the numbers
Alto Neuroscience has a market capitalization of $923.0 million based on 39.24M shares outstanding. With trailing EPS of $-2.31, Alto Neuroscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.5% below its 50-day average and 1.1% below its 200-day average.
Average daily trading volume is 543.14K shares, or about $12.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANRO valuation vs. peer median
| Metric | ANRO | Peer median | Difference |
|---|---|---|---|
| Market cap | $922.97M | $900.62M | +2% |
| Avg. volume | 543.14K | 754.33K | -28% |
Peer median across 8 companies: MLTX, KURA, ANL, SPTX, RIGL, CYRX, ALMS, JBIO.
Valuation
- Market cap
- $922.97M
- EPS (TTM)
- $-2.31
- Shares outstanding
- 39.24M
Price and trading
- Previous close
- 23.69
- Open
- 23.39
- Day range
- 23.33 – 24.40
- 52-week range
- 5.23 – 37.48
- 52-week change
- +295.96%
- Beta
- —
- Volume
- 346.25K
- Average volume
- 543.14K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 922.97M
- Forward Pe
- -7.16
- Eps
- -2.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 37.48
- Week52 Low
- 5.23
- Avg Volume
- 543.14K
- Shares Outstanding
- 39.24M
- Ma50
- 30.76
- Ma200
- 23.78
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -37.25%
- Pct From52w Low
- 350.14%